Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2350 of 3173 entries
View as:

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers

Phase: N/A Priority: Normal
NCT ID: NCT01181700 Org: User:
Start: 10/31/10 End: 01/31/11 Due: 01/31/12

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Phase: N/A Priority: Normal
NCT ID: NCT02847650 Org: User:
Start: 10/17/16 End: 01/29/18 Due: 01/29/19

A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01472848 Org: User:
Start: 04/30/11 End: 08/31/11 Due: 08/31/12

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01792635 Org: User:
Start: 12/31/12 End: 05/31/14 Due: 05/31/15

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT00240747 Org: User:
Start: 06/30/00 End: 01/31/05 Due: 01/31/06

A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00251030 Org: User:
Start: 11/30/05 End: 01/31/06 Due: 01/31/07

Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey

Phase: N/A Priority: Normal
NCT ID: NCT06680206 Org: User:
Start: 10/10/24 End: 11/20/24 Due: 11/20/25

A Bioequivalence Study Comparing Two Different Tafamidis Formulations

Phase: N/A Priority: Normal
NCT ID: NCT02217813 Org: User:
Start: 10/31/14 End: 11/30/14 Due: 11/30/15

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03351751 Org: User:
Start: 11/08/17 End: 02/28/18 Due: 02/28/19

Randomized Trial in Adult Participants With Acute Migraines

Phase: N/A Priority: Normal
NCT ID: NCT04571060 Org: User:
Start: 10/27/20 End: 10/22/21 Due: 10/22/22

Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01396187 Org: User:
Start: 07/31/11 End: 05/31/12 Due: 05/31/13

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00413660 Org: User:
Start: 01/31/07 End: 08/31/08 Due: 08/31/09

Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01050751 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

Phase: N/A Priority: Normal
NCT ID: NCT00293722 Org: User:
Start: 01/31/06 End: 02/28/13 Due: 02/28/14

A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03260595 Org: User:
Start: 09/13/17 End: 11/27/17 Due: 11/27/18

Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT04721821 Org: User:
Start: 01/22/21 End: 11/29/21 Due: 11/29/22

A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06418529 Org: User:
Start: 05/15/24 End: 07/19/24 Due: 07/19/25

A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib

Phase: N/A Priority: Normal
NCT ID: NCT02311946 Org: User:
Start: 01/31/15 End: 04/30/15 Due: 04/30/16

Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.

Phase: N/A Priority: Normal
NCT ID: NCT03634345 Org: User:
Start: 09/12/18 End: 12/13/18 Due: 12/13/19

A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06177457 Org: User:
Start: 12/20/23 End: 12/02/24 Due: 12/02/25

Description of Relugolix Use in Patients With Prostate Cancer Within the VHA

Phase: N/A Priority: Normal
NCT ID: NCT06462014 Org: User:
Start: 06/19/24 End: 12/13/24 Due: 12/13/25

Benzonatate Dose Tolerance Study

Phase: N/A Priority: Normal
NCT ID: NCT01690975 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13

This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00418522 Org: User:
Start: 03/31/07 End: 08/31/08 Due: 08/31/09

Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01258088 Org: User:
Start: 11/30/10 End: 12/07/10 Due: 12/07/11

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Phase: N/A Priority: Normal
NCT ID: NCT00141661 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07